Restriction Spectrum Imaging for Tissue Microstructure Characterization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current magnetic resonance imaging (MRI) techniques face limitations in characterizing biological tissue microstructure, particularly in differentiating between hindered and restricted diffusion, which is crucial for identifying healthy and diseased tissues, due to their inability to effectively separate length scale and orientation information.

Innovation Solution

The use of restriction spectrum imaging (RSI) technology, which employs a linear mixture model to relate diffusion MRI signals to biological tissue parameters, optimizing diffusion MRI acquisition by combining various diffusion gradient strengths, waveforms, times, and sensitivity factors, and using spherical harmonics to model tissue microstructure with minimal assumptions, allowing for non-invasive biomarker identification of healthy and diseased tissues.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional MRI techniques are used to characterize biological tissue, then imaging capability is provided, but the ability to differentiate between hindered and restricted diffusion and separate length scale information is insufficient

Engineering Contradiction:
Improvetissue characterization precisionVSAvoiddiffusion process differentiation difficulty
Core Design Contradiction:
Measurement precisionVSDifficulty of detecting and measuring

Solution Approach 1:

The patent segments the diffusion process into distinct components by separating hindered and restricted diffusion signals. It divides the diffusion weighting conditions into multiple sets with different b-values and gradient directions, allowing independent analysis of each diffusion component. This segmentation enables precise characterization of tissue microstructure by resolving overlapping diffusion processes that conventional MRI cannot distinguish.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces additional dimensions to the diffusion measurement by incorporating multiple b-values, multiple gradient directions, and multiple diffusion times. This multi-dimensional approach transforms the conventional single-parameter diffusion measurement into a comprehensive multi-parameter characterization, enabling separation of length scale information and accurate differentiation between hindered and restricted diffusion mechanisms.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Measurement precision

If diffusion MRI data is collected with multiple b-values and gradient directions, then tissue microstructure characterization is improved, but data acquisition complexity and processing requirements increase

Engineering Contradiction:
Improvemicrostructure characterization precisionVSAvoidacquisition and processing complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent designs a unified diffusion MRI protocol that simultaneously achieves multiple objectives: characterizing tissue microstructure, differentiating diffusion mechanisms, and providing biomarker identification. The same multi-parameter acquisition protocol serves all these functions, eliminating the need for separate specialized scans and reducing overall system complexity despite the enhanced measurement capabilities.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent systematically varies diffusion parameters including b-values, gradient directions, and diffusion times to optimize the measurement of specific tissue properties. By changing these parameters in a controlled manner, the protocol efficiently extracts multiple types of information from a single acquisition session, reducing the need for repeated scans and minimizing processing complexity.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If restriction spectrum imaging is used to separate fine and coarse scale diffusion processes, then biomarker accuracy is improved, but computational processing requirements increase

Engineering Contradiction:
Improvebiomarker accuracyVSAvoidcomputational processing power
Core Design Contradiction:
Measurement precisionVSPower

Solution Approach 1:

The patent performs preliminary signal processing steps during the acquisition phase by pre-calculating diffusion weighting factors and organizing data in a format optimized for analysis. This preliminary preparation reduces the computational burden during the actual biomarker extraction phase, allowing accurate separation of fine and coarse scale diffusion processes with reduced processing power requirements.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent extracts and isolates specific diffusion components (hindered and restricted diffusion signals) from the complex MRI data through targeted processing algorithms. By extracting only the relevant information needed for biomarker identification rather than processing the entire dataset, the method achieves high accuracy while minimizing computational power consumption.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

RSI technology enables detailed characterization of tissue microstructure by separating fine and coarse scale diffusion processes, providing accurate biomarkers for tissue health and disease, including tumor classification and prediction of clinical outcomes like Alzheimer's conversion risk.

Implementation Method 1

NMR is a physical property in which the nuclei of atoms absorb and re-emit electromagnetic energy at a specific resonance frequency in the presence of a magnetic field

Methodology Applied
Scientific EffectNuclear magnetic resonance: Resonance

Implementation Method 2

diffusion MRI data... diffusion gradient directions, diffusion gradient strengths, sensitivity factors (b-values), or diffusion times

Methodology Applied
Scientific EffectDiffusion: Diffusion

Data Source

PatentUS9404986B2Measuring biological tissue parameters using diffusion magnetic resonance imaging
Publication Date: 2016.08.02 RGT UNIV OF CALIFORNIA
  • US9404986B2 patent drawing
  • US9404986B2 patent drawing
  • US9404986B2 patent drawing

AI summary

Methods, devices and systems are disclosed for measuring biological tissue parameters using restriction spectrum magnetic resonance imaging. In one aspect, a method of characterizing a biological structure includes determining individual diffusion signals from magnetic resonance imaging (MRI) data in a set of MRI images that include diffusion weighting conditions (e.g., diffusion gradient directions, diffusion gradient strengths, sensitivity factors (b-values), or diffusion times), combining the individual diffusion signals to determine a processed diffusion signal corresponding to at least one location within one or more voxels of the MRI data, calculating one or more parameters from the processed diffusion signal by using the diffusion weighting conditions, and using the one or more parameters to identify a characteristic of the biological structure, in which the one or more parameters include values over a range of one or more diffusion length scales based on at least one of diffusion distance or diffusion rate.